HDAC8 and nonpapillary renal cell carcinoma: Subsequent co‐IP assays demonstrated that depleting HDAC8 or treating ccRCC cells with PCI‐34051 decreased the binding of HIF‐2α to ETS1 (Figure 5H–J).